Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies Malignancies

NCT04823091 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

T-Cell Lymphocytic Leukemia
T-Cell Chronic Lymphocytic Leukemia
T Cell Non-Hodgkin Lymphoma

Interventions

DRUG: Fludarabine + Cyclophosphamide + CAR7-T Cells

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Collaborators

[object Object]
[object Object]